Diabetes

Learn of Updates in the Management of Prediabetes and Type II Diabetes

by

OSUWexnerbloglogo2014 Learn of Updates in the Management of Prediabetes and and Type II Diabetes. Learn of Updates in the Management of Prediabetes and and Type II Diabetes. The International Diabetes Federation estimates there are 537 million individuals with diabetes worldwide. And that’s not even counting the patients that go undiagnosed. In the US, we estimate that 1/3 of eligible patients are not screened. Even with screening, there’s a gigantic gap in prediabetes diagnosis and treatment. Those in Primary care are really at the forefront of diabetes & prediabetes care. With 11% of the adult population affected by Diabetes, every healthcare worker must become comfortable with the care and treatment of these patients. So today to help Dr. Mao discuss the updates in the prevention and treatment of diabetes, we’ve invited her colleague Jennifer Sabatino who is a Doctor of Pharmacy and practicing Clinical Pharmacist at Ohio State University. They will cover the basics and updates over the past half a decade or so including both non-pharmacologic and pharmacologic treatment options.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand the epidemiology and definition of Prediabetes and Type II diabetes (T2DM).
  • Be familiar with the different treatment options for Prediabetes to prevent progression to T2DM.
  • Understand the pharmacologic and non-pharmacologic treatments for T2DM.
  • Recognize the place in therapy of Glucagon-Like Peptide Receptor Agonists (GLP-1 RA) and Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) for T2DM.
  • Explore a new class of medications for diabetes treatment, the Glucose-Dependent Insulinotropic Polypeptide (GIP)/Glucagon-Like Peptide Receptor Agonist (GLP-1 RA).

You’ll also learn about the following:

  • Supplements
  • Prediabetes treatment Outcomes
  • Pregnancy and lactation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn the Latest About Type 1 Diabetes on Webcast

by

OSUWexnerbloglogo2014 Viewers will learn the Latest About Type 1 Diabetes on this webcast. To discuss the topic, we’re joined Dr. Kathleen Wyne, Professor of Medicine in the Division of Endocrinology, and Dr. Elizabeth Buschur, Assistant Professor of Medicine in the Division of Endocrinology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: review epidemiology of T1D; understand diagnosis of T1D; describe management of T1D with insulin (basal and bolus); and understand special management for unique populations of T1D.

You’ll also learn about the following:

  • Percentage of patients using continuous glucose monitors
  • Concept of time in range for blood glucose
  • Antibody testing for PCPs
  • GLP1 agonists or SGLT2 inhibitors for patients with type 1 diabetes
  • Challenges of transitions of care
  • Basic recommendations for best patients for insulin pumps or continuous glucose monitors

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Experts Discuss Inpatient Management of Diabetes on CME Webcast

by

OSUWexnerbloglogo2014 Experts Discuss Inpatient Management of Diabetes on CME Webcast. In the 100 years since the discovery of insulin by Banting and Best, insulin remains the cornerstone of treatment for diabetes but we now have better formulations of insulin as well as new oral diabetes medications that are improving the lives of diabetics like never before. But when patients with diabetes are admitted to the hospital with medical or surgical conditions, the management of diabetes can become complicated. On this CME webcast, we are going to show you the management strategies that you can use for your inpatients with diabetes to ensure the best outcomes. Let me welcome my guests. Dr. Kathleen Dungan is an endocrinologist and Professor of Internal Medicine from the Ohio State University. And Dr. Roger Harty is an Assistant Professor of Internal Medicine, also from the Division of Endocrinology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: describe the scope of hyperglycemia in the hospital and rationale for glucose control; illustrate management strategies based upon illness severity and other clinical characteristics; describe methods for determining inpatient insulin dosing; and provide an overview of discharge considerations for patients with diabetes in the inpatient setting.

You’ll also learn about the following:

  • Critical illness and diabetes control
  • Risks of hypoglycemia

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.